Banu Anlar - Neurology

Author Information

Banu Anlar is affiliated with the Department of Pediatric Neurology at Hacettepe University Ihsan Dogramaci Children's Hospital in Ankara, Turkey. Her work primarily focuses on pediatric neurology, contributing significantly to the understanding and treatment of neurological disorders in children.

Research Contributions

Banu Anlar has made substantial contributions to the field of neurology, with a specific focus on pediatric conditions. Her recent research explores various topics including treatment options for subacute sclerosing panencephalitis, ocular myasthenia post-multisystem inflammatory syndrome in children, and the role of urine neopterin in diagnosing childhood acute demyelinating diseases. Additionally, she has investigated the presence of myelin oligodendrocyte glycoprotein antibodies in hereditary citrullinemia and examined the relationship between functional classification systems in cerebral palsy. Her work also extends to the safety and efficacy of treatments for pediatric multiple sclerosis and other immune-mediated disorders of the central nervous system.

Aliases

Banu Anlar is also known by other names including B Anlar and B. Anlar, as reflected in her publications and academic contributions.

Publication and Citation Metrics

Metric	Value
Paper Count	286
Citation Count	4554
H-index	32

Publications:

Options in the Treatment of Subacute Sclerosing Panencephalitis: Implications for Low Resource Areas

DOI: 10.1007/s11940-022-00710-x

Year: 2022

Correction to: Options in the Treatment of Subacute Sclerosing Panencephalitis: Implications for Low Resource Areas

DOI: 10.1007/s11940-022-00717-4

Year: 2022

New-Onset Ocular Myasthenia after Multisystem Inflammatory Syndrome in Children

DOI: 10.1016/j.jpeds.2022.02.046

Year: 2022

Urine neopterin in childhood acute demyelinating diseases: Potential for differential diagnosis.

DOI: 10.1016/j.msard.2022.103662

Year: 2022

Relationship among four functional classification systems and parent interpredicted intelligence level in children with different clinical types of cerebral palsy.

DOI: 10.1080/17518423.2022.2051629

Year: 2022

Investigating myelin oligodendrocyte glycoprotein antibodies in hereditary citrullinemia

DOI: 10.1016/j.mehy.2022.110781

Year: 2022

International Consensus Recommendations for the Treatment of Pediatric NMDAR Antibody Encephalitis

DOI: 10.1212/NXI.0000000000001052

Year: 2021

Synthetic MRI in Neurofibromatosis Type 1

DOI: 10.3174/ajnr.A7214

Year: 2021

Immunization in multiple sclerosis and other childhood immune-mediated disorders of the central nervous system: A review of the literature.

DOI: 10.1016/j.ejpn.2021.06.002

Year: 2021

Safety and efficacy of teriflunomide in paediatric multiple sclerosis (TERIKIDS): a multicentre, double-blind, phase 3, randomised, placebo-controlled trial

DOI: 10.1016/S1474-4422(21)00364-1

Year: 2021

Is Research Ongoing?

What is Aquaporin 4?

Are There Specific Nutrients in the Mediterranean Diet That Benefit Neurological Health?

What is the Prognosis for CFS Patients?

What are the Mechanisms Behind B Cell Depletion in Neurology?

How Does Neurogenetics Influence Treatment Strategies?

What is Robotic Surgery in Neurocare?

What Are the Treatment Options for Multiple Sclerosis?

What are Common CNS Disorders?

What are the benefits of DMTs?

Partnered Content Networks

Relevant Topics